RenovoRx Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . RenovoRx
RNXT Stock  USD 1.20  0.02  1.64%   
Analyzing historical trends in various income statement and balance sheet accounts from RenovoRx's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting RenovoRx's valuation are summarized below:
Gross Profit
146 K
Market Capitalization
44.6 M
Enterprise Value Revenue
127.8078
Revenue
240 K
Earnings Share
(0.41)
There are currently one hundred ten trending fundamental ratios for RenovoRx that can be evaluated and compared over time across competitors. All traders should check out RenovoRx's recent fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 301.7 M in 2025. Enterprise Value is likely to gain to about 294.4 M in 2025
Check RenovoRx financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among RenovoRx's main balance sheet or income statement drivers, such as Net Interest Income of 403.2 K, Interest Income of 64.3 K or Depreciation And Amortization of 5.1 K, as well as many indicators such as Price To Sales Ratio of 5.3 K, Dividend Yield of 0.0 or PTB Ratio of 67.37. RenovoRx financial statements analysis is a perfect complement when working with RenovoRx Valuation or Volatility modules.
  
Build AI portfolio with RenovoRx Stock
Check out the analysis of RenovoRx Correlation against competitors.
For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.

RenovoRx Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.8 M8.1 M4 M
Slightly volatile
Short and Long Term Debt Total237.7 K250.2 K8 M
Slightly volatile
Other Current Liabilities785.8 K1.3 M467.2 K
Slightly volatile
Total Current Liabilities1.3 M1.9 M1.2 M
Slightly volatile
Accounts Payable532.8 K586 K517.5 K
Very volatile
Cash6.2 M7.2 M3.7 M
Slightly volatile
Non Currrent Assets Other122 K116.1 K30.6 K
Slightly volatile
Cash And Short Term Investments6.2 M7.2 M3.7 M
Slightly volatile
Common Stock Total Equity800900981
Slightly volatile
Common Stock Shares Outstanding21 M23.6 M18.2 M
Slightly volatile
Liabilities And Stockholders Equity6.8 M8.1 M4 M
Slightly volatile
Non Current Liabilities Total1.6 M1.7 M9 M
Slightly volatile
Other Current Assets571.1 K631 K321.5 K
Slightly volatile
Other Stockholder Equity30.7 M54.7 M12.5 M
Slightly volatile
Total Liabilities5.3 M3.6 M10.2 M
Slightly volatile
Total Current Assets6.8 M7.8 M4 M
Slightly volatile
Capital Stock1.3 K2 K1.1 K
Slightly volatile
Common Stock1.3 K2 K1.1 K
Slightly volatile
Current Deferred Revenue248.8 K279.9 K305.2 K
Slightly volatile
Long Term Debt18.4 K20.7 K22.6 K
Slightly volatile
Short and Long Term Debt2.2 M2.5 M2.7 M
Slightly volatile
Short Term Debt56.4 K59.4 K1.9 M
Slightly volatile
Property Plant Equipment4.8 K5.4 K5.9 K
Slightly volatile

RenovoRx Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income64.3 K127.7 K65.6 K
Pretty Stable
Depreciation And Amortization5.1 K5.4 K2.6 M
Slightly volatile
Selling General Administrative3.8 M5 M2 M
Slightly volatile
Other Operating Expenses8.3 M11 M5.5 M
Slightly volatile
Research Development4.5 M6 M3.5 M
Slightly volatile
Total Operating Expenses8.3 M11 M5.5 M
Slightly volatile
Selling And Marketing Expenses4.6 M5.2 M5.6 M
Slightly volatile

RenovoRx Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings2.2 M1.8 M2.8 M
Slightly volatile
Stock Based Compensation1.2 M1.2 M294.1 K
Slightly volatile
Begin Period Cash Flow1.1 M1.2 M5 M
Pretty Stable
Total Cash From Financing Activities8.4 M15.1 M5.2 M
Slightly volatile
End Period Cash Flow5.8 M7.2 M3.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.3 K6 K6.6 K
Slightly volatile
Stock Based Compensation To Revenue21.8424.5726.7902
Slightly volatile
Capex To Depreciation1.341.51.6358
Slightly volatile
EV To Sales5.2 K5.9 K6.4 K
Slightly volatile
Payables Turnover0.01560.01290.016
Slightly volatile
Research And Ddevelopement To Revenue112126137
Slightly volatile
Capex To Revenue0.220.250.2736
Slightly volatile
Cash Per Share0.03050.03210.1723
Pretty Stable
Days Payables Outstanding21.5 K29.2 K23.2 K
Slightly volatile
Income Quality0.751.03530.8918
Slightly volatile
Net Debt To EBITDA1.120.62682.1685
Slightly volatile
Current Ratio5.974.10063.9927
Slightly volatile
Capex Per Share1.0E-41.0E-46.0E-4
Slightly volatile
Revenue Per Share2.0E-42.0E-42.0E-4
Slightly volatile
Interest Debt Per Share0.00280.0030.463
Slightly volatile
Debt To Assets0.03740.03943.5139
Slightly volatile
Days Of Payables Outstanding17 K19.2 K20.9 K
Slightly volatile
Ebt Per Ebit1.10.80350.9968
Very volatile
Quick Ratio5.974.10063.9927
Slightly volatile
Net Income Per E B T1.171.141.0249
Slightly volatile
Cash Ratio5.473.74753.6769
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0177
Slightly volatile
Fixed Asset Turnover0.120.130.1454
Slightly volatile
Debt Ratio0.03740.03943.5139
Slightly volatile
Price Sales Ratio5.3 K6 K6.6 K
Slightly volatile
Asset Turnover0.00420.00480.0052
Slightly volatile

RenovoRx Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap301.7 M287.3 M134.3 M
Slightly volatile
Enterprise Value294.4 M280.4 M138.5 M
Pretty Stable

RenovoRx Fundamental Market Drivers

Cash And Short Term Investments7.2 M

RenovoRx Upcoming Events

7th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About RenovoRx Financial Statements

RenovoRx shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although RenovoRx investors may analyze each financial statement separately, they are all interrelated. The changes in RenovoRx's assets and liabilities, for example, are also reflected in the revenues and expenses on on RenovoRx's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue279.9 K248.8 K
Total Revenue43 K45.1 K
Stock Based Compensation To Revenue 24.57  21.84 
Research And Ddevelopement To Revenue 126.10  112.10 
Capex To Revenue 0.25  0.22 
Ebit Per Revenue(229.60)(241.08)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for RenovoRx Stock Analysis

When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY